疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

/ \$ T& H3 G) }' ]. ZApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
( d" @" h1 N& z
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 N, A( m$ p' n9 A4 Vaccine manufacturing 44
8 l8 Y% m6 ~$ H3 ~5 Evolution of adjuvants across the centuries 58
* C2 }/ ^0 n6 j2 H. T6 Vaccine additives and manufacturing residuals in the United States:
2 j" a/ w: |' B& Y+ Nlicensed vaccines 71
& ~: w. C1 B  ?; ^- f/ O. s7 Passive immunization 80
/ e3 t* N' X# {3 c8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
3 w$ B1 y9 J, w6 M/ P10 Anthrax vaccines 127
11 Cholera vaccines 141
5 _, p* }% ]+ {; q12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
2 c, C& \; F" c& D0 k# U4 H14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
9 a. @4 D- Z0 m9 c5 e. R% e17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
: v% O8 Q; G" u9 |! f1 v$ Q20 Measles vaccines 352
21 Meningococcal vaccines 388
+ m& t- b% Z3 C, f+ `) \9 M22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
0 O6 S7 D" ]  g: D8 b# W26 Pneumococcal polysaccharide vaccines 542
: Y# q; i8 V+ K: T2 Q27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
% V* n- X5 d7 y32 Smallpox and vaccinia 718
9 \" J5 y* b; d33 Tetanus toxoid 746
% H  m" w6 y  ]4 b/ I% p# U34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
9 V: i' a5 l* H+ ?' h3 M, C37 Varicella vaccine 837
38 Yellow fever vaccine 870
  T. y: I5 N/ E, X2 V39 Zoster vaccine 969
40 Combination vaccines 981
) g2 e# r8 p- o* HSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
* k9 Z; [7 j% U, v; P! K$ `42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
/ s/ Z+ L& P) ]2 p8 w. }4 T% z44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
1 G5 `+ ?7 U$ w7 E. }0 g7 d50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
, _: K  d- h$ z9 c52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
: a0 i  c5 `( @- q6 `9 J56 Parasitic disease vaccines 1154
0 O7 A6 o8 `; ]. N) n7 d/ h, e57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
- q) ~  g: w5 j- G7 o7 Z59 Streptococcus group B vaccines 1176
  T: n( n2 Z* x1 S5 }) Z6 v8 k60 Technologies for making new vaccines 1182
1 f1 x5 R, n3 P1 [9 j+ C  T1 n61 Alternative vaccine delivery methods 1200
2 {5 \/ b4 i* v# _& D6 p  c3 l62 The development of gene-based vectors for immunization 1232
1 z2 M, ~7 y9 gSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
/ C' z. h) |# m/ j4 E6 \64 Vaccination of human immunodeficiency virus-infected persons 1257
5 j, X& k2 P& X; f/ ]. O65 Vaccines for international travel 1270
' Z/ F9 }/ p* g66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
  X/ I$ Z; \! S8 w$ S68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
. j! L0 C1 w" l* g70 Immunization in developing countries 1369
, t# V- B9 n8 O9 U5 U0 H71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
! x* R/ q. Y- o3 y# N76 Vaccine safety 1464
' H& K1 N5 O6 K* j0 F/ H- R7 l77 Legal issues . 1481
78 Ethics 1508
$ E, y) N% d: A7 K& V



$ l% N8 k# V% R# ]1 U0 S# a+ K

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition
: [' k" y( S; ^3 g
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link? ... 1&uk=3810996606
+ O* Q( `$ P7 c+ z* P, Q$ n
1 V) \: B; \. `SECTION 1: General aspects of vaccination
: ]" g% n" h4 u* i' r$ l1 A short history of vaccination 1
. o7 X2 }: Y$ c6 R3 `% R1 c2 Vaccine immunology 14
7 Z0 w, r( a, q4 q: \+ N' i( Q3 t+ v3 The vaccine industry 33
4 Vaccine manufacturing 44
' K1 J* w5 T# e: p9 \: N3 ?5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
0 O3 N: [/ Y" m. r' w; d8 General immunization practices 88
# I# ^  `" J& P% vSECTION 2: Licensed vaccines
& A& W9 U' [  P5 ]9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
5 V* G! z# m1 r- d  L4 w! A8 B0 u12 Diphtheria toxoid 153
8 x, _* s* J7 _13 Haemophilus influenzae vaccines 167
$ W5 l/ v: A9 ]8 d14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
9 D2 Z  E% v7 N: C' O5 A$ n$ Q16 Human papillomavirus vaccines 235
1 c; j) b+ s+ ^  X, I8 O) Z17 Inactivated influenza vaccines 257
, M' C# f2 p6 `. i  G. r" g3 j' s' ]+ u$ i18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
$ z( t" J- G9 V3 P# R! o. l, {( ~23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
  L1 P/ r7 \* n' [. z8 Z26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
' @' O' |5 F% b30 Rotavirus vaccines . 669
31 Rubella vaccine 688
& r# B! I0 M' _3 u) o0 B; C32 Smallpox and vaccinia 718
: q; F" I* v4 G- s2 [: N33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
1 t! u; W! m% S* q4 h0 V35 Tuberculosis vaccines 789
7 b3 y6 b* M9 |* T" _5 s  i* g36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
: ]1 l- B% H/ C39 Zoster vaccine 969
40 Combination vaccines 981
0 X) G! p( j  ?! JSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
; B8 s, @7 R* U6 N44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
, P1 M6 z  [- ~; j4 X) x46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
! a1 T$ w/ ~. O, Y" a3 z50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
/ p; n' Y8 F% i! L; l1 Z5 y* G52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
9 l# M! ^8 r4 `9 g: Z" D54 Noninfectious disease vaccines 1138
) G+ W$ T: ?6 ~: N7 F- u( _3 K55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
/ @/ W4 H4 s, x56 Parasitic disease vaccines 1154
" q' k' n) T9 n- q, A& \57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
. C+ x9 h5 ]$ I& w59 Streptococcus group B vaccines 1176
9 x4 o& j3 o/ S! U" D+ Q7 g60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
1 C# G8 j" ~. f) o! X# A" M62 The development of gene-based vectors for immunization 1232
! d* a2 {: a9 v5 c8 [/ B" ISECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
; w0 ~% X9 ~7 h4 g5 K5 R; }* Q5 J66 Vaccines for health care personnel 1290
+ D# Q3 ?: J$ I9 F' W# T/ H1 rSECTION 5: Public health and regulatory issues
- _  K/ }& A$ h( c9 A9 s+ O67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
# O2 A% ]& A+ c73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
% [* J. Q# i3 f0 g3 U8 g78 Ethics 1508
! _8 S& n9 Q. i4 s4 j6 ~4 e, h
' ]- n2 P0 e, D8 P4 G+ k

casarett

Vaccines, 6e, 2012
( u8 p) S; ]" l6 p
. U& f) M3 w! T. x% Z, M" i0 X7 y7 kHardcover: 1570 pages
, B# v2 k3 I  w, X$ U+ c9 GPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
ISBN-10: 1455700908
Size: 52.3mb (original pdf)

2013 BMA Medical Book Awards Highly Commended in Public Health!
* P7 b$ |3 x; K3 T' e- L3 w  u. vApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
0 L4 U/ ~: I- y" x6 Q; ZUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
+ g8 ^4 t" f! o- X" j' ~5 DGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
, H6 P7 D. J: @) t$ }* H  I2 VAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
1 v& S. L9 S4 E  }% B$ dClearly visualize concepts and objective data through an abundance of tables and figures.
" B8 C/ o2 {& w+ a4 x1 TPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
" o- L" V) H% q' N. wMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96
- Q8 q* Q( ?" e. ~& A1 u* ?